Involvement of a cysteine protease in the secretion process of human xylosyltransferase I
- PMID: 20198421
- DOI: 10.1007/s10719-010-9283-4
Involvement of a cysteine protease in the secretion process of human xylosyltransferase I
Abstract
Xylosylation of core proteins takes place in the Golgi-apparatus as the transfer of xylose from UDP-xylose to specific serine residues in proteoglycan core proteins. This initial and rate-limiting step in glycosaminoglycan biosynthesis is catalyzed by human xylosyltransferase I (XT-I). XT-I is proteolytically cleaved from the Golgi surface and shed in its active form into the extracellular space. The secreted, circulating glycosyltransferase represents a serum biomarker for various diseases with an altered proteoglycan metabolism, whereas a physiological function of secreted XT-I is still unknown. To shed light on the secretion process of XT-I and on its biological function, the cleavage site was examined and the group of proteases involved in the cleavage was identified in this study. The peptide mass fingerprint from partly purified secreted XT-I revealed the cleavage site to be localized in the aminoterminal 231 amino acids. The addition of a cysteine protease inhibitor cocktail to cells recombinantly expressing XT-I led to a concentration-dependent shift of enzyme activity towards the cell lysates attended by consistent total intracellular and extracellular XT-I activities. In conclusion, our findings provide a first insight into the XT-I secretion process regulated by a cysteine protease and may contribute to understanding the biological and pathological role of this process.
Similar articles
-
Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II.J Mol Biol. 2000 Dec 8;304(4):517-28. doi: 10.1006/jmbi.2000.4261. J Mol Biol. 2000. PMID: 11099377
-
Recognition of acceptor proteins by UDP-D-xylose proteoglycan core protein beta-D-xylosyltransferase.J Biol Chem. 1997 Apr 25;272(17):11171-5. doi: 10.1074/jbc.272.17.11171. J Biol Chem. 1997. PMID: 9111016
-
Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity.Biochem J. 2005 Mar 1;386(Pt 2):227-36. doi: 10.1042/BJ20041206. Biochem J. 2005. PMID: 15461586 Free PMC article.
-
Human xylosyltransferases in health and disease.Cell Mol Life Sci. 2007 Jun;64(12):1498-517. doi: 10.1007/s00018-007-7069-z. Cell Mol Life Sci. 2007. PMID: 17437056 Free PMC article. Review.
-
The never-ending story of peptide O-xylosyltransferase.Cell Mol Life Sci. 2004 Apr;61(7-8):794-809. doi: 10.1007/s00018-003-3278-2. Cell Mol Life Sci. 2004. PMID: 15095004 Free PMC article. Review.
Cited by
-
Engineering β1,4-galactosyltransferase I to reduce secretion and enhance N-glycan elongation in insect cells.J Biotechnol. 2015 Jan 10;193:52-65. doi: 10.1016/j.jbiotec.2014.11.013. Epub 2014 Nov 25. J Biotechnol. 2015. PMID: 25462875 Free PMC article.
-
Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum.Biochem Biophys Res Commun. 2015 Apr 10;459(3):469-74. doi: 10.1016/j.bbrc.2015.02.129. Epub 2015 Mar 3. Biochem Biophys Res Commun. 2015. PMID: 25748573 Free PMC article.
-
Identification of Putative Non-Substrate-Based XT-I Inhibitors by Natural Product Library Screening.Biomolecules. 2020 Oct 21;10(10):1467. doi: 10.3390/biom10101467. Biomolecules. 2020. PMID: 33096778 Free PMC article.
-
The Impact of Inflammatory Stimuli on Xylosyltransferase-I Regulation in Primary Human Dermal Fibroblasts.Biomedicines. 2022 Jun 19;10(6):1451. doi: 10.3390/biomedicines10061451. Biomedicines. 2022. PMID: 35740472 Free PMC article.
-
Activin A-Mediated Regulation of XT-I in Human Skin Fibroblasts.Biomolecules. 2020 Apr 14;10(4):609. doi: 10.3390/biom10040609. Biomolecules. 2020. PMID: 32295230 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources